CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Ampliphi Biosciences Corp  (APHB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Ampliphi Biosciences's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

APHB Gross Margin (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Revenue Change -72.82 % -72.64 % -82.81 % -79.72 % 0.98 %
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 35 # 57 # 0 # 0 # 0
Seq. Revenue Change -3.45 % 31.82 % -24.14 % -71.84 % -2.83 %
Seq. Gross Profit Change - - - - -


Commenting Second Quarter 2017 Gross Margin
Ampliphi Biosciences Corp experienced contraction in Gross Profit by -3.45 % to $0 millions and Revenue by -3.45 %, while Gross Margin fell to 100 % a new company low.

Observing second quarter 2017 results within Biotechnology & Drugs industry 3 other companies have achieved higher Gross Margin. While overall Gross Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Gross Margin
APHB's Gross Margin second quarter 2017 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 4
Healthcare Sector # 10
Overall # 35

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Jun 30 2017)  

You need to upgrade your Flash Player


Financial Statements
Ampliphi Biosciences's (Jun 30 2017) Gross Profit $ 0 APHB's Income Statement
Ampliphi Biosciences's (Jun 30 2016) Gross Profit $ 0 Quarterly APHB's Growth
APHB's Profits by Division See APHB's Profits by Segment

Other Gross Margin Profitability Ratios
APHB's Cumulative Gross Margin
Biotechnology & Drugs Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
APHB's Gross Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for APHB's Competitors
Gross Margin Profit Margin for Ampliphi Biosciences's Suppliers
Gross Margin Profit Margin for APHB's Customers

You may also want to know
APHB's Annual Growth Rates APHB's Profitability Ratios APHB's Asset Turnover Ratio APHB's Dividend Growth
APHB's Roe APHB's Valuation Ratios APHB's Financial Strength Ratios APHB's Gross Profit Growth
APHB's Roa APHB's Inventory Turnover Ratio APHB's Growth Rates APHB's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Jun 30 2017, within Biotechnology & Drugs Industry Gross MarginJun 30 2017 MRQ Gross ProfitJun 30 2017 MRQ Revenue
Spark Therapeutics, Inc.  100.00 %$ 1.483 $ 1.483 
Crispr Therapeutics Ag  100.00 %$ 3.582 $ 3.582 
Cytomx Therapeutics, Inc.  100.00 %$ 8.752 $ 8.752 
Neuralstem, Inc.  100.00 %$ 0.003 $ 0.003 
Novavax Inc  100.00 %$ 6.732 $ 6.732 
Curis Inc  100.00 %$ 2.061 $ 2.061 
Cannabics Pharmaceuticals Inc.  100.00 %$ 0.002 $ 0.002 
Proteostasis Therapeutics, Inc.  100.00 %$ 1.147 $ 1.147 
Cerecor Inc.  100.00 %$ 0.158 $ 0.158 
Coherus Biosciences, Inc.  100.00 %$ 1.395 $ 1.395 
Oncobiologics, Inc.  100.00 %$ 0.303 $ 0.303 
Dimension Therapeutics, Inc.  100.00 %$ 4.369 $ 4.369 
Intellia Therapeutics, Inc.  100.00 %$ 5.917 $ 5.917 
Momenta Pharmaceuticals Inc  100.00 %$ 23.570 $ 23.570 
Kite Pharma, Inc.  100.00 %$ 10.052 $ 10.052 
Idera Pharmaceuticals, Inc.  100.00 %$ 0.187 $ 0.187 
Innovus Pharmaceuticals, Inc.  100.00 %$ 2.039 $ 2.039 
Mymetics Corp  100.00 %$ 0.317 $ 0.317 
Myokardia Inc  100.00 %$ 5.625 $ 5.625 
Nantkwest, Inc.  100.00 %$ 0.014 $ 0.014 
Enumeral Biomedical Holdings, Inc.  100.00 %$ 0.379 $ 0.379 
Enzon Pharmaceuticals, Inc.  100.00 %$ 6.775 $ 6.775 
Fate Therapeutics Inc  100.00 %$ 1.026 $ 1.026 
Juno Therapeutics, Inc.  100.00 %$ 21.268 $ 21.268 
Regen Biopharma Inc  100.00 %$ 0.110 $ 0.110 
Tg Therapeutics, Inc.  100.00 %$ 0.038 $ 0.038 
Aeolus Pharmaceuticals, Inc.  100.00 %$ 0.013 $ 0.013 
Ampliphi Biosciences Corp  100.00 %$ 0.028 $ 0.028 
Regenerx Biopharmaceuticals Inc  100.00 %$ 0.013 $ 0.013 
Voyager Therapeutics, Inc.  100.00 %$ 1.177 $ 1.177 
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
DJOFL's Profile
Stock Price
DJOFL's Financials
DJOFL's Expectations
Business Description
Fundamentals
Charts & Quotes
DJOFL's News
Suppliers
DJOFL's Competitors
Customers & Markets
Economic Indicators
DJOFL's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com